4
Changes in Ownership
Amneal Pharmaceuticals, Inc. Filed Acc 0001628280-24-009481
Options or other derivatives
- Co-CEO acquired 1,703,704 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Patel Chintu Co-CEO | 2024-03-04 | Grant or award · Restricted Stock Units | +370,370 | 370,370 | D | ||
| Patel Chintu Co-CEO | 2024-03-04 | Grant or award · Performance-Based Restricted Stock Units | +1,333,334 | 1,333,334 | D | ||
Loading xslF345X05/wk-form4_1709764798.xml…